Search by PDB author

Crystal structure of Eph receptor and ephrin complex
Descriptor:	Ephrin type-A receptor 4, Ephrin-B2
Authors:	Qin, H.N, Song, J.X.
Deposit date:	2009-04-03
Release date:	2009-10-27
Last modified:	2023-11-01
Method:	X-RAY DIFFRACTION (2.5 Å)
Cite:	Structural characterization of the EphA4-ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity J.Biol.Chem., 2009

8RQ2

Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation III
Descriptor:	23S ribosomal RNA, 5S ribosomal RNA, Apidaecins type 88, ...
Authors:	Lauer, S, Nikolay, R, Spahn, C.
Deposit date:	2024-01-17
Release date:	2024-05-22
Method:	ELECTRON MICROSCOPY (2.44 Å)
Cite:	Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88. Nat Commun, 15, 2024

8RPY

Escherichia coli 50S subunit in complex with the antimicrobial peptide Api137
Descriptor:	23S ribosomal RNA, 5S ribosomal RNA, Apidaecins type 137, ...
Authors:	Lauer, S, Nikolay, R, Spahn, C.
Deposit date:	2024-01-17
Release date:	2024-05-22
Method:	ELECTRON MICROSCOPY (2.64 Å)
Cite:	Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88. Nat Commun, 15, 2024

8RPZ

Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation I
Descriptor:	23S ribosomal RNA, 5S ribosomal RNA, Apidaecins type 88, ...
Authors:	Lauer, S, Nikolay, R, Spahn, C.
Deposit date:	2024-01-17
Release date:	2024-05-22
Method:	ELECTRON MICROSCOPY (2.44 Å)
Cite:	Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88. Nat Commun, 15, 2024

8RQ0

Escherichia coli 50S subunit in complex with the antimicrobial peptide Api88 - conformation II
Descriptor:	23S ribosomal RNA, 5S ribosomal RNA, Apidaecins type 88, ...
Authors:	Lauer, S, Nikolay, R, Spahn, C.
Deposit date:	2024-01-17
Release date:	2024-05-22
Method:	ELECTRON MICROSCOPY (2.44 Å)
Cite:	Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88. Nat Commun, 15, 2024

4ZJV

crystal structure of EGFR kinase domain in complex with Mitogen-inducible gene 6 protein
Descriptor:	ERBB receptor feedback inhibitor 1, Epidermal growth factor receptor
Authors:	Eck, M.J, Park, E, Lee, B.
Deposit date:	2015-04-29
Release date:	2015-08-12
Last modified:	2023-11-15
Method:	X-RAY DIFFRACTION (2.7 Å)
Cite:	Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6. Nat.Struct.Mol.Biol., 22, 2015

5ULA

Crystal Structure of the First Bromodomain of Human BRD4 in Complex With Cyclic Vinylogous Amide Inhibitor MS402
Descriptor:	3-chloranyl-~{N}-(4-methoxyphenyl)-4-[(2-methyl-3-oxidanylidene-cyclopenten-1-yl)amino]benzamide, Bromodomain-containing protein 4
Authors:	Plotnikov, A.N, Joshua, j, Zhou, M.-M.
Deposit date:	2017-01-24
Release date:	2017-03-22
Last modified:	2024-03-06
Method:	X-RAY DIFFRACTION (1.5 Å)
Cite:	BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc. Natl. Acad. Sci. U.S.A., 114, 2017

6SEN

TEAD4 bound to a FAM181A peptide
Descriptor:	Protein FAM181A, SULFATE ION, Transcriptional enhancer factor TEF-3
Authors:	Scheufler, C, Villard, F.
Deposit date:	2019-07-30
Release date:	2019-11-20
Last modified:	2024-01-24
Method:	X-RAY DIFFRACTION (1.65 Å)
Cite:	Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors. Protein Sci., 29, 2020

6SEO

TEAD4 bound to a FAM181B peptide
Descriptor:	Protein FAM181B, Transcriptional enhancer factor TEF-3
Authors:	Scheufler, C, Villard, F.
Deposit date:	2019-07-30
Release date:	2019-11-20
Last modified:	2024-01-24
Method:	X-RAY DIFFRACTION (2.55 Å)
Cite:	Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors. Protein Sci., 29, 2020

4F3I

Crystal structure of the first bromodomain of human BRD4 in complex with MS417 inhibitor
Descriptor:	1,2-ETHANEDIOL, Bromodomain-containing protein 4, methyl [(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate
Authors:	Joshua, J, Zhou, M.-M, Plotnikov, A.N.
Deposit date:	2012-05-09
Release date:	2012-09-12
Last modified:	2023-09-13
Method:	X-RAY DIFFRACTION (1.4 Å)
Cite:	Down-regulation of NF-{kappa}B Transcriptional Activity in HIV-associated Kidney Disease by BRD4 Inhibition. J.Biol.Chem., 287, 2012

5OAQ

TEAD4 COMPLEXED WITH YAP PEPTIDE AND MYRISTATE (COVALENTLY BOUND)
Descriptor:	GLYCEROL, MYRISTIC ACID, Transcriptional coactivator YAP1, ...
Authors:	Kallen, J.
Deposit date:	2017-06-23
Release date:	2017-10-11
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (1.95 Å)
Cite:	Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ. Protein Sci., 26, 2017

4NUE

Crystal structure of the first bromodomain of human BRD4 in complex with MS267 inhibitor
Descriptor:	1,2-ETHANEDIOL, 4-[(E)-(2-amino-4-hydroxy-3,5-dimethylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide, Bromodomain-containing protein 4
Authors:	Plotnikov, A.N, Joshua, J, Zhou, M.-M.
Deposit date:	2013-12-03
Release date:	2014-04-02
Last modified:	2023-09-20
Method:	X-RAY DIFFRACTION (1.3 Å)
Cite:	Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains J.Med.Chem., 56, 2013

4NUC

Crystal structure of the first bromodomain of human BRD4 in complex with MS435 inhibitor
Descriptor:	1,2-ETHANEDIOL, 4-[(E)-(4-hydroxy-3,5-dimethylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide, Bromodomain-containing protein 4
Authors:	Plotnikov, A.N, Joshua, J, Zhou, M.-M.
Deposit date:	2013-12-03
Release date:	2014-04-02
Last modified:	2023-09-20
Method:	X-RAY DIFFRACTION (1.4 Å)
Cite:	Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains J.Med.Chem., 56, 2013

4NUD

Crystal structure of the first bromodomain of human BRD4 in complex with MS436 inhibitor
Descriptor:	1,2-ETHANEDIOL, 4-[(E)-(2-amino-4-hydroxy-5-methylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide, Bromodomain-containing protein 4
Authors:	Plotnikov, A.N, Joshua, J, Zhou, M.-M.
Deposit date:	2013-12-03
Release date:	2014-04-02
Last modified:	2024-02-28
Method:	X-RAY DIFFRACTION (1.2 Å)
Cite:	Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains J.Med.Chem., 56, 2013

6GE6

X-ray structure of TEAD4(E263A+Y429F mutant) complexed with YAP(wildtype): The role of residual flexibility and water molecules in the adaptation of a bound intrinsically disordered protein to mutations at a binding interface
Descriptor:	MYRISTIC ACID, PHOSPHATE ION, Transcriptional coactivator YAP1, ...
Authors:	Kallen, J.
Deposit date:	2018-04-25
Release date:	2018-09-19
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

6GE5

TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.05A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Descriptor:	MYRISTIC ACID, Transcriptional coactivator YAP1, Transcriptional enhancer factor TEF-3
Authors:	Kallen, J.
Deposit date:	2018-04-25
Release date:	2018-09-19
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (2.05 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

6GEC

TEAD4 (216-434) COMPLEXED WITH YAP PEPTIDE (60-100);S94A AND MYRISTOATE (COVALENTLY BOUND) AT 1.70A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Descriptor:	MYRISTIC ACID, Transcriptional coactivator YAP1, Transcriptional enhancer factor TEF-3
Authors:	Kallen, J.
Deposit date:	2018-04-26
Release date:	2018-09-19
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (1.7 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

6GEI

TEAD4 (216-434);E263A+Y429F COMPLEXED WITH YAP PEPTIDE (60- 100);S94A AND MYRISTOATE (COVALENTLY BOUND TO LYS344, NOT CYS367!) AT 1.65A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Descriptor:	MYRISTIC ACID, PHOSPHATE ION, Transcriptional coactivator YAP1, ...
Authors:	Kallen, J.
Deposit date:	2018-04-26
Release date:	2018-09-19
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (1.65 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

6GEG

TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) AT 2.23A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Descriptor:	MYRISTIC ACID, Transcriptional coactivator YAP1, Transcriptional enhancer factor TEF-3
Authors:	Kallen, J.
Deposit date:	2018-04-26
Release date:	2018-09-19
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (2.23 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

6GEK

TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.28A (P212121 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Descriptor:	MYRISTIC ACID, Transcriptional coactivator YAP1, Transcriptional enhancer factor TEF-3
Authors:	Kallen, J.
Deposit date:	2018-04-26
Release date:	2018-09-19
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (2.28 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

6GEE

TEAD4 (216-434);E263A COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) AT 1.96A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Descriptor:	MYRISTIC ACID, Transcriptional coactivator YAP1, Transcriptional enhancer factor TEF-3
Authors:	Kallen, J.
Deposit date:	2018-04-26
Release date:	2018-09-19
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (1.96 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

6GE3

X-ray structure of TEAD4 (wildtype) complexed with YAP (wildtype): The role of residual flexibility and water molecules in the adaptation of a bound intrinsically disordered protein to mutations at a binding interface
Descriptor:	GLYCEROL, MYRISTIC ACID, Transcriptional coactivator YAP1, ...
Authors:	Kallen, J.
Deposit date:	2018-04-25
Release date:	2018-09-19
Last modified:	2024-05-15
Method:	X-RAY DIFFRACTION (1.85 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

6HIL

X-ray structure of TEAD1(Y421H mutant) complexed with YAP(wildtype): Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy
Descriptor:	MYRISTIC ACID, Transcriptional coactivator YAP1, Transcriptional enhancer factor TEF-1
Authors:	Kallen, J.
Deposit date:	2018-08-30
Release date:	2019-04-03
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy. Febs J., 286, 2019

6HIK

X-ray structure of TEAD4(Y429H) mutant) complexed with YAP (wildtype): Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy
Descriptor:	MYRISTIC ACID, PHOSPHATE ION, Transcriptional coactivator YAP1, ...
Authors:	Kallen, J.
Deposit date:	2018-08-30
Release date:	2019-04-03
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (1.65 Å)
Cite:	Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy. Febs J., 286, 2019

6GE4

TEAD4 (216-434);E263A COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 1.97A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA
Descriptor:	MYRISTIC ACID, Transcriptional coactivator YAP1, Transcriptional enhancer factor TEF-3
Authors:	Kallen, J.
Deposit date:	2018-04-25
Release date:	2018-09-19
Last modified:	2024-01-17
Method:	X-RAY DIFFRACTION (1.97 Å)
Cite:	Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Protein Sci., 27, 2018

<1 2 3 4 567 >

Total results:	153
Displayed results:	25
Sorted by:	Hit score (from highest)